Home » Psychology news » Blood markers of brain cell damage higher over short term in COVID-19 patients than in Alzheimer’s patients, study finds

Blood markers of brain cell damage higher over short term in COVID-19 patients than in Alzheimer’s patients, study finds

January 13, 2022 by

Patients hospitalized for COVID-19 had higher levels over the short term of blood proteins known to rise with neurological damage than non-COVID-19 patients diagnosed with Alzheimer's disease.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>